Evidence map›Paper›PMID 35729553›Full record

ArticleJournal of nanobiotechnology2022

Composition tunability of semiconductor radiosensitizers for low-dose X-ray induced photodynamic therapy.

Lei Chen, Jinghui Zhang, Lihua Xu, Luchao Zhu, Jinpeng Jing, Yushuo Feng, Zongzhang Wang, Peifei Liu, Wenjing Sun, Xiangmei Liu and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. In Situ Synthesis of a Tumor Microenvironment-Activated Radiosensitizing CuAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lei ChenState Key Laboratory of Molecular Vaccinology and Molecular, Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, People's Republic of China.
Jinghui ZhangState Key Laboratory of Molecular Vaccinology and Molecular, Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, People's Republic of China.
Lihua XuState Key Laboratory of Molecular Vaccinology and Molecular, Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, People's Republic of China.
Luchao ZhuDepartment of Radiation Oncology, Cancer Center, The First Affiliated Hospital of Xiamen University, Xiamen, 361003, People's Republic of China.
Jinpeng JingState Key Laboratory of Molecular Vaccinology and Molecular, Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, People's Republic of China.
Yushuo FengState Key Laboratory of Molecular Vaccinology and Molecular, Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, People's Republic of China.
Zongzhang WangState Key Laboratory of Molecular Vaccinology and Molecular, Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, People's Republic of China.
Peifei LiuState Key Laboratory of Molecular Vaccinology and Molecular, Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, People's Republic of China.
Wenjing SunState Key Laboratory of Molecular Vaccinology and Molecular, Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, People's Republic of China. sunwj0102@zju.edu.cn.
Xiangmei LiuState Key Laboratory of Organic Electronics and Information Displays & Institute of Advanced Materials (IAM), Jiangsu Key Laboratory for Biosensors, Nanjing University of Posts & Telecommunications, Nanjing, 210023, People's Republic of China. iamxmliu@njupt.edu.cn.
Yimin LiDepartment of Radiation Oncology, Cancer Center, The First Affiliated Hospital of Xiamen University, Xiamen, 361003, People's Republic of China. lym05@xmu.edu.cn.
Hongmin ChenState Key Laboratory of Molecular Vaccinology and Molecular, Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, People's Republic of China. hchen@xmu.edu.cn.

Funding

Fundamental Research Funds for the Central Universities 20720180054National Natural Science Foundation of China 61775103National Natural Science Foundation of China 81771977National Natural Science Foundation of China 82001956National Natural Science Foundation of China 82172007the First Affiliated Hospital of Xiamen University Translational Medicine Research Incubation Fund XFY2020004the National Postdoctoral Program for Innovative Talents BX20200196the open research fund of State Key Laboratory of Organic Electronics and Information Displays, the open research fund of National Facility for Translational Medicine (Shanghai) TMSK-2021-102the Science Fund for Distinguished Young Scholars of Fujian Province 2021J06007Xiamen Science and Technology Planning Guidance Project 3502Z20214ZD1004Xiamen Science and Technology Plan Project 3502Z20183017
6 · The paper itself

Abstract

Radiation therapy is one of the most commonly used methods in clinical cancer treatment, and radiosensitizers could achieve enhanced therapeutic efficacy by incorporating heavy elements into structures. However, the secondary excitation of these high-Z elements-doped nanosensitizers still imply intrinsic defects of low efficiency. Herein, we designed Bi-doped titanium dioxide nanosensitizers in which high-Z Bi ions with adjustable valence state (Bi

Indexed as

NeoplasmsPhotochemotherapyRadiation-Sensitizing AgentsHumansReactive Oxygen SpeciesSemiconductorsX-RaysRadiation-Sensitizing AgentsReactive Oxygen SpeciesComposition tunabilityRadiosensitizersReactive oxygen speciesSemiconductorsX-ray induced photodynamic therapy

Identifiers

PMID35729553
PMCPMC9210653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.